Log In
BCIQ
Print this Print this
 

Nanolipolee 007

  Manage Alerts
Collapse Summary General Information
Company Melanovus Oncology Inc.
DescriptionIntravenous nanoparticle formulation containing Leelamine (bark of pine tree)
Molecular Target Protein kinase B gamma (AKT3) (PKBG) ; Signal transducer and activator of transcription 3 (STAT3)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMelanoma
Indication DetailsTreat advanced melanoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/09/2015

Undisclosed

Undisclosed

0

Get a free BioCentury trial today